Related Experiment Video
Updated: Feb 1, 2026

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity
Benjamin M Vincent1, Daniel F Tardiff1, Jeff S Piotrowski1
1Yumanity Therapeutics, 790 Memorial Drive, Suite 2C, Cambridge, MA 02139, USA.
Researchers identified a new therapeutic target for neurodegenerative diseases like Parkinson's. Inhibiting stearoyl-CoA desaturase (SCD) reduces alpha-synuclein toxicity, offering a potential treatment strategy.
Area of Science:
- Neuroscience
- Biochemistry
- Drug Discovery
Background:
- Neurodegenerative diseases lack disease-modifying treatments due to limited understanding of disease mechanisms.
- Alpha-synuclein (α-syn) misfolding and aggregation are implicated in Parkinson's disease and other disorders.
- Identifying novel therapeutic targets is crucial for developing effective treatments.
Purpose of the Study:
- To identify a new therapeutic target for diseases caused by alpha-synuclein (α-syn) aggregation.
- To explore the potential of inhibiting stearoyl-CoA desaturase (SCD) as a therapeutic strategy.
Main Methods:
- Employed an integrated discovery paradigm and unbiased phenotypic screening.
- Identified compounds inhibiting stearoyl-CoA desaturase (SCD) for cytoprotection against α-syn toxicity.
- Utilized human induced pluripotent stem cell (iPSC) neuronal models to assess α-syn toxicity reduction.
Main Results:
- Discovered that inhibiting stearoyl-CoA desaturase (SCD) confers cytoprotection against α-syn-mediated toxicity.
- Demonstrated that reducing unsaturated membrane lipids by inhibiting SCD lowers α-syn toxicity in iPSC neuronal models.
- Identified a series of compounds effective in inhibiting SCD and mitigating α-syn toxicity.
Conclusions:
- Inhibition of fatty acid desaturation presents a promising therapeutic approach for Parkinson's disease.
- Targeting stearoyl-CoA desaturase (SCD) offers a novel strategy for treating synucleinopathies.
- Findings support further investigation into SCD inhibitors for neurodegenerative disease treatment.
Related Concept Videos
Feedback Inhibition
Enzyme Inhibition
Inhibition of Cdk Activity
α-Alkylation of Ketones via Enolate Ions
Factors Affecting α-Alkylation of Ketones: Choice of Base
The reaction involving bases like EtO− whose conjugate acid EtOH (pKa = 15.9) is stronger than the ketone (pKa = 19.2) results in an equilibrium mixture with higher ketone concentration. As a consequence,...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

